Citius Pharmaceuticals Statistics

Total Valuation

CTXR has a market cap or net worth of $25.50 million. The enterprise value is $22.51 million.

Market Cap	25.50M
Enterprise Value	22.51M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025, after market close.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CTXR has 7.73 million shares outstanding. The number of shares has increased by 11.16% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	+11.16%
Shares Change (QoQ)	+4.03%
Owned by Insiders (%)	1.26%
Owned by Institutions (%)	12.61%
Float	7.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	2.56
PS Ratio	n/a
Forward PS	0.54
PB Ratio	0.34
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40, with a Debt / Equity ratio of 0.00.

Current Ratio	0.40
Quick Ratio	0.09
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -47.63% and return on invested capital (ROIC) is -31.57%.

Return on Equity (ROE)	-47.63%
Return on Assets (ROA)	-23.83%
Return on Capital (ROIC)	-31.57%
Revenue Per Employee	n/a
Profits Per Employee	-$1.75M
Employee Count	23
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CTXR has paid $576,000 in taxes.

Income Tax	576,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.40% in the last 52 weeks. The beta is 1.31, so CTXR's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-82.40%
50-Day Moving Average	4.55
200-Day Moving Average	13.14
Relative Strength Index (RSI)	41.55
Average Volume (20 Days)	185,504

Short Selling Information

The latest short interest is 595,333, so 7.70% of the outstanding shares have been sold short.

Short Interest	595,333
Short Previous Month	523,868
Short % of Shares Out	7.70%
Short % of Float	7.80%
Short Ratio (days to cover)	13.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.00M
Pretax Income	-35.62M
Net Income	-40.19M
EBITDA	-41.99M
EBIT	-42.00M
Earnings Per Share (EPS)	-$5.97

Full Income Statement

Balance Sheet

The company has $3.25 million in cash and $262,865 in debt, giving a net cash position of $2.99 million or $0.39 per share.

Cash & Cash Equivalents	3.25M
Total Debt	262,865
Net Cash	2.99M
Net Cash Per Share	$0.39
Equity (Book Value)	74.10M
Book Value Per Share	9.67
Working Capital	-21.59M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-28.20M
Capital Expenditures	n/a
Free Cash Flow	-28.20M
FCF Per Share	-$3.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTXR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.16%
Shareholder Yield	-11.16%
Earnings Yield	-157.59%
FCF Yield	-110.59%

Analyst Forecast

The average price target for CTXR is $54.50, which is 1,551.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$54.50
Price Target Difference	1,551.52%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 26, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Nov 26, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1